Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheet

v3.10.0.1
Condensed Balance Sheet - USD ($)
Sep. 30, 2018
Dec. 31, 2017
Current Assets:    
Cash and cash equivalents $ 4,591,722 $ 8,899,154
Marketable securities 7,974,010 17,931,941
Prepaid expenses and other current assets 1,154,898 1,304,541
Total Current Assets 13,720,630 28,135,636
Security Deposits 30,785 30,785
Equipment, Net 123,480 121,460
Total Assets 13,874,895 28,287,881
Current Liabilities:    
Accounts payable and accrued expenses 3,331,646 3,233,926
Deferred Research and Development Arrangement   375,000
Other Liabilities 29,850 56,724
Warrant Liabilities 4,101,504 7,853,635
Total Liabilities 7,463,000 11,519,285
Commitments and Contingencies (note 14)
Stockholders' Equity:    
Preferred stock, par value $0.0001, 10,000,000 authorized shares, none issued and outstanding
Common stock, par value $0.0001, 75,000,000 and 50,000,000 authorized shares, 31,751,939 and 31,725,114 issued and outstanding 3,175 3,173
Additional paid-in capital 158,008,879 157,141,021
Accumulated other comprehensive loss (29,487) (56,886)
Accumulated deficit (151,570,672) (140,318,712)
Total Stockholders' Equity 6,411,895 16,768,596
Total Liabilities and Stockholders' Equity $ 13,874,895 $ 28,287,881